Di seguito sono riportate le informazioni acquisite su VALNEVA, che non è ancora inclusa nel nostro perimetro di ricerca.

Per richiedere una valutazione di questa azienda e l'inserimento nel Ranking OpenCorporation o se hai dati ulteriori, diversi e più aggiornati di quanto pubblicato in questa scheda aziendale OpenCorporation, scrivi a info@opencorporation.org così che il nostro team possa tenerne conto.

Aggiornato il 8 luglio 2023

Descrizione attività
(disponibile solo in inglese)

Manufacture of pharmaceutical preparations (NACE2 2120)

This company is primarily engaged in the manufacture of vaccines and drugs for the prevention and treatment of viral diseases. It was established in 1999 by the Grimaud Group. Its registered office is located in Lyon, France. The company was founded with the aim to have a better understanding the biological properties of embryonic stem (ES) cells and to use this knowledge for practical applications in human and animal health. With its several years of research investments, the company has become the world leader in ES cells research. Its distinctive expertise in the field of avian ES cells led to the development and successful commercialization of EBx platform, a series of fully-documented cells lines derived from chicken and duck ES cells. EBx is an innovative, safe and cost-effective production platform for the industrial manufacture of human and veterinary viral vaccines and recombinant proteins. The company's technical and scientific expertise in virus research enables it to develop a second proprietary technology, the 3D-Screen platform, a cell-based drug screening platform that allows the discovery of original small-molecules that prevent viral replication through allosteric modulation of key target viral proteins. The company has licensed EBx platform to several major pharmaceutical and biotech companies in the Europe and the United States for non-exclusive or exclusive applications. It has also exploits these platforms for its own internal research and development for the production and prevention of a series of infectious diseases.

  • VALNEVA

  • France (FR)
  • Tipo di azienda: Corporate
  • Impresa controllante: N/D
  • Amministratore Delegato (CEO): Mr Frederic Louis Marie Grimaud
  • Compenso Amministratore Delegato: N/D
  • Sito web: www.valneva.com

Parametri finanziari

Numero di dipendenti

778
722
532
508

Fatturato 1

377
372
130
134

EBIT 1

-113
-61
-55
-720

EBITDA 1

-73
-47
-45
8

1 numeri espressi in milioni

  • RepRisk indicator (ultimo mese):  N/D

Dialogo sociale

  • Transnational Corporate Agreement (TCA): N/D
  • Global Framework Agreement (GFA): N/D
  • Societas Europaea (SE):
  • Bangladesh Accord: N/D

Comitati Aziendali Europei

Standard e certificazioni

  • Global Compact:
  • › N/D
  • CDP (Carbon Disclosure Project): N/D
  • Modern Slavery Statement: N/D
  • Transparency Index: N/D
  • SA8000 Social Accountability: N/D
  • Bilancio Integrato: N/D
  • ISO26000: N/D
  • Linee Guida Ocse:
  • Social Development Goals (SDGs): N/D

Certificazione Global Reporting Initiative

  • Global Reporting Initiative standards: N/D
  • Global Reporting Initiative GRI G4: N/D

Altre dichiarative aziendali

  • Responsabilità sociale d'impresa:
    N/D
  • Accessibilità: N/D

Policy

  • Policy sulla formazione: N/D
  • Policy a tutela del diritto alla salute e alla sicurezza nei luoghi di lavoro dove opera l'azienda: N/D
  • Policy a tutela del diritto alla salute e alla sicurezza nei luoghi di lavoro lungo filiera: N/D
  • Policy sulla diversità: N/D

Dichiarazioni universali

Dichiarazioni e trattati riconosciuti dal paese in cui l'azienda ha la sede legale

  • Dichiarazione universale dei Diritti Umani:
  • Convenzione europea dei diritti dell'uomo (CEDU):
  • Carta dei Diritti Fondamentali dei Lavoratori CDFL (Carta di Strasburgo 1989):
  • Carta dei diritti fondamentali dell'Unione Europea CDF UE (Carta di Nizza 2000):
  • Trattato sul funzionamento dell'Unione europea TFUE:
  • Sede legale in un Paese OCSE:
  • ILO C029 - Forced Labour Convention, 1930 (No. 29):
  • ILO C087 - Freedom of Association and Protection of the Right to Organise Convention, 1948 (No. 87):
  • ILO C098 - Right to Organise and Collective Bargaining Convention, 1949 (No. 98):
  • ILO C100 - Equal Remuneration Convention, 1951 (No. 100):
  • ILO C105 - Abolition of Forced Labour Convention, 1957 (No. 105):
  • ILO C111 - Discrimination (Employment and Occupation) Convention, 1958 (No. 111):
  • ILO C138 - Minimum Age Convention, 1973 (No. 138):
  • ILO C182 - Worst Forms of Child Labour Convention, 1999 (No. 182):

Direttive applicate alle sedi nella UE 27

  • D. 80/987/EEC:
  • D. 89/391/EEC:
  • D. 98/59/EC:
  • D. 2000/43/EC:
  • D. 2000/78/EC:
  • D. 2001/23/EC:
  • D. 2001/86/EC del Consiglio:
  • D. 2002/14/EC:
  • D. 2002/73/EC:
  • D. 2003/72/EC del Consiglio:
  • D. 2005/56/EC del PE e del Consiglio:
  • D. 2009/38/EC:
  • D. 2004/25/EC:
  • D. 2011/35/EU:

Presenza nei principali ranking

  • Global 100 Most Sustainable Corporations: N/D
  • Global CSR Rep Trak 100: N/D
  • BrandZ Top 100 Most Valuable US Brands: N/D
  • The Worlds Best Multinational Workplaces: N/D
  • The Gartner Supply Chain Top 25: N/D
  • The Worlds Most Innovative Companies: N/D
  • The Diversity Inc Top 50 Companies: N/D
  • Best Global Websites: N/D
  • Green Ranking Global Top 500: N/D
  • Green Ranking Global Top 100: N/D

Sindacati di riferimento